Not found

David Beers, PhD

Associate Research Professor of Neurology, Institute for Academic Medicine
Associate Research Member, Research Institute
Houston Methodist


dbeers@houstonmethodist.org
Publications

Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies
Beers, D & Appel, SH 2019, The Lancet Neurology, vol. 18, no. 2, pp. 211-220. https://doi.org/10.1016/S1474-4422(18)30394-6

Functional alterations of myeloid cells during the course of Alzheimer's disease
Thome, AD, Faridar, A, Beers, DR, Thonhoff, JR, Zhao, W, Wen, S, Pascual, B, Masdeu, JC & Appel, SH 2018, Molecular Neurodegeneration, vol. 13, no. 1, pp. 61. https://doi.org/10.1186/s13024-018-0293-1

Head-to-head comparison of 11C-PBR28 and 18F-GE180 for quantification of the translocator protein in the human brain
Zanotti-Fregonara, P, Pascual, B, Rizzo, G, Yu, M, Pal, N, Beers, D, Carter, R, Appel, SH, Atassi, N & Masdeu, JC 2018, Journal of Nuclear Medicine, vol. 59, no. 8, pp. 1260-1266. https://doi.org/10.2967/jnumed.117.203109

Expanded autologous regulatory T-lymphocyte infusions in ALS A phase I, first-in-human study
Thonhoff, JR, Beers, DR, Zhao, W, Pleitez, M, Simpson, EP, Berry, JD, Cudkowicz, ME & Appel, SH 2018, Neurology: Neuroimmunology and NeuroInflammation, vol. 5, no. 4, e465. https://doi.org/10.1212/NXI.0000000000000465

Expanded autologous regulatory T-lymphocyte infusions in ALS
Thonhoff, JR, Beers, DR, Zhao, W, Pleitez, M, Simpson, EP, Berry, JD, Cudkowicz, ME & Appel, SH 2018, Neurology - Neuroimmunology Neuroinflammation, vol. 5, no. 4.

The role of regulatory T lymphocytes in amyotrophic lateral sclerosis
Beers, D, Zhao, W & Appel, SH 2018, JAMA Neurology, vol. 75, no. 6, pp. 656-658. https://doi.org/10.1001/jamaneurol.2018.0043

An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosis
Fournier, CN, Schoenfeld, D, Berry, JD, Cudkowicz, ME, Chan, J, Quinn, C, Brown, RH, Salameh, JS, Tansey, MG, Beers, DR, Appel, SH & Glass, JD 2018, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, pp. 1-8. https://doi.org/10.1080/21678421.2017.1421666

Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes
Zhao, W, Beers, DR, Hooten, KG, Sieglaff, DH, Zhang, A, Kalyana-Sundaram, S, Traini, CM, Halsey, WS, Hughes, AM, Sathe, GM, Livi, GP, Fan, GH & Appel, SH 2017, JAMA Neurology, vol. 74, no. 6, pp. 677-685. https://doi.org/10.1001/jamaneurol.2017.0357

ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity
Beers, DR, Zhao, W, Wang, J, Zhang, X, Wen, S, Neal, D, Thonhoff, JR, Alsuliman, AS, Shpall, EJ, Rezvani, K & Appel, SH 2017, JCI Insight, vol. 2, no. 5, pp. e89530. https://doi.org/10.1172/jci.insight.89530

A robust, good manufacturing practice–compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy
Alsuliman, A, Appel, SH, Beers, DR, Basar, R, Shaim, H, Kaur, I, Zulovich, J, Yvon, E, Muftuoglu, M, Imahashi, N, Kondo, K, Liu, E, Shpall, EJ & Rezvani, K 2016, Cytotherapy, vol. 18, no. 10, pp. 1312-1324. https://doi.org/10.1016/j.jcyt.2016.06.012

TDP-43 activates microglia through NF-?B and NLRP3 inflammasome
Zhao, W, Beers, DR, Bell, S, Wang, J, Wen, S, Baloh, RH & Appel, SH 2015, Experimental Neurology, vol. 273, pp. 24-35. https://doi.org/10.1016/j.expneurol.2015.07.019

Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis
Hooten, KG, Beers, D, Zhao, W & Appel, SH 2015, Neurotherapeutics, vol. 12, no. 2, pp. 364-375. https://doi.org/10.1007/s13311-014-0329-3

The Role of Regulatory T Cells and Microglia in Amyotrophic Lateral Sclerosis
Beers, DR, Zhao, W, Hooten, KG & Appel, SH 2015, . in S David (ed.), Neuroinflammation: New Insights into Beneficial and Detrimental Functions. Wiley, pp. 235-249. https://doi.org/10.1002/9781118732748.ch15

Role of Inflammation in Neurodegenerative Diseases
Appel, SH, Beers, DR & Zhao, W 2014, . in Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders. Elsevier, pp. 380-395. https://doi.org/10.1016/B978-0-12-398270-4.00025-2

Neuroimmunology of Amyotrophic Lateral Sclerosis
Henkel, JS, Beers, DR, Zhao, W & Appel, SH 2014, . in Neuroinflammation and CNS Disorders. Wiley, pp. 185-209. https://doi.org/10.1002/9781118406557.ch8

Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis
Zhao, W, Beers, D & Appel, SH 2013, Journal of Neuroimmune Pharmacology, vol. 8, no. 4, pp. 888-899. https://doi.org/10.1007/s11481-013-9489-x

Erratum: Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival [EMBO Mol Med 5, 1] DOI: 10.1002/emmm.201201544
Henkel, JS, Beers, D, Wen, S, Rivera, AL, Toennis, KM, Appel, JE, Zhao, W, Moore, DH, Powell, SZ-E & Appel, SH 2013, EMBO Molecular Medicine, vol. 5, no. 2. https://doi.org/10.1002/emmm.201390002

Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival
Henkel, JS, Beers, D, Wen, S, Rivera, AL, Toennis, KM, Appel, JE, Zhao, W, Moore, DH, Powell, SZ-E & Appel, SH 2013, EMBO Molecular Medicine, vol. 5, no. 1, pp. 64-79. https://doi.org/10.1002/emmm.201201544

Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms
Zhao, W, Beers, D, Liao, B, Henkel, JS & Appel, SH 2012, Neurobiology of Disease, vol. 48, no. 3, pp. 418-428. https://doi.org/10.1016/j.nbd.2012.07.008

Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS
Liao, B, Zhao, W, Beers, DR, Henkel, JS & Appel, SH 2012, Experimental Neurology, vol. 237, no. 1, pp. 147-152. https://doi.org/10.1016/j.expneurol.2012.06.011

VIEW FULL PUBLICATIONS